Slide 1 Environment self Non-self Dangerous Pathogenic Immune system Tolerance Immune response The immune system is still the big black box Slide 2 Bacteria Viruses parasites…

Magda Carneiro-Sampaio, MD, PhD Hospital das Clínicas da Faculdade de Medicina Universidade de São Paulo (FMUSP), Brazil Primary Immunodeficiencies in 910 Brazilian…

Slide 1 PRIMARY & SECONDARY ANTIBODY DEFICIENCY 1 ANTIBODIES & IMMUNOGLOBULINS PRIMARY ANTIBODY DEFICIENCY The European internet-based patient and research database…

Slide 1 IPOPI Advocacy & Media Training Workshop A message from your Health Minister David Watters Consultant 14-15 September 2012 Belgrade Art Hotel (BAH) Belgrade,…

Slide 1 IPOPI Advocacy & Media Training Workshop A message from your Health Minister David Watters Consultant 14-15 September 2012 Belgrade Art Hotel (BAH) Belgrade,…

Slide 1 PRIMARY & SECONDARY ANTIBODY DEFICIENCY 1 ANTIBODIES & IMMUNOGLOBULINS PRIMARY ANTIBODY DEFICIENCY The European internet-based patient and research database…

Hindawi Publishing Corporation Clinical and Developmental Immunology Volume 2011, Article ID 283239, 4 pages doi:10.1155/2011/283239 Case Report Successful Treatment of Chronic…

1. A systematic literature review andreport on the efficacy of intravenous immunoglobulin therapy and its risks Final report v04 6 September 2004 2. contents937.doc Contents1…

Research on rare diseases follows a long and complex pathway (1) Identification of a clinical phenotype cohort clinical expertise databases technical platforms Therapeutic…

Call to Action – Newborn Screening for Rare Diseases The European Union’s (EU) added value in the field of rare diseases is well known. From the European Reference